跳至主要内容
临床试验/JPRN-UMIN000024268
JPRN-UMIN000024268已完成未知

Clinical research of CLENAFIN - Clinical research of CLENAFI

KAKEN PHARMACEUTICAL CO., LTD.0 个研究点目标入组 223 人开始时间: 2016年10月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
223

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Clinically diagnosed Proximal Subungual Onychomycosis (PSO) or Total Dystrophic Onychomycosis (TDO). 2. Presence of any nail abnormalities without trichophytosis unguium (e.g. nail psoriasis, lichen planus affecting nails, traumatic onychodystrophy) as determined by the investigator. 3. Treatment with CLENAFIN, oral antifungal drugs or antifungal agent for external use within 3 months prior to informed consent. 4. Plannning to receive the following treatment during the study period: (1) oral antifungal drug (2) antifungal agent for external use without CLENAFIN. (3) laser radiation (4) occlusive dressing technique (e.g. urea ointment) 5. Has a negative fungal culture at the central mycology lab. (confirmed by investigator after the subjects' informed consent)

研究者

相似试验